These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2808505)

  • 1. Circulating immune complexes in Buerger's disease. Endarteritis obliterans in young men.
    Roncon de Albuquerque R; Delgado L; Correia P; Torrinha JF; Serrão D; Braga A
    J Cardiovasc Surg (Torino); 1989; 30(5):821-5. PubMed ID: 2808505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of circulatory immune complexes in thromboangiitis obliterans (Buerger's disease).
    Gulati SM; Saha K; Kant L; Thusoo TK; Prakash A
    Angiology; 1984 May; 35(5):276-81. PubMed ID: 6426348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune mechanisms in thromboangiitis obliterans (Buerger's disease): the role of tobacco antigen and the major histocompatibility complex.
    Papa M; Bass A; Adar R; Halperin Z; Schneiderman J; Becker CG; Brautbar H; Mozes E
    Surgery; 1992 May; 111(5):527-31. PubMed ID: 1598672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endarteritis obliterans in the pathogenesis of Buerger's disease from the pathological and immunohistochemical points of view.
    Kobayashi M; Sugimoto M; Komori K
    Circ J; 2014; 78(12):2819-26. PubMed ID: 25298073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Population genetics, immunologic evaluation and Buerger's disease. Projection through a personal study comprising 127 cases of juvenile arteriopathy].
    Schmitt J; Schmidt C; Alan C; Haller C; Perrier P
    Bull Acad Natl Med; 1993 Oct; 177(7):1153-62; discussion 1162-4. PubMed ID: 8149255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buerger's disease and anticardiolipin antibodies.
    Pereira de Godoy JM; Braile DM
    J Cardiovasc Med (Hagerstown); 2009 Oct; 10(10):792-4. PubMed ID: 19455050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral and cellular immune response to Buerger's disease.
    Ehteshamfar SM; Afshari JT; Modaghegh MS; Mahmoudi M; Kazemzadeh GH; Kermani FS
    Vascular; 2020 Aug; 28(4):457-464. PubMed ID: 32212917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies in thromboangiitis obliterans (Buerger's disease).
    Gulati SM; Madhra K; Thusoo TK; Nair SK; Saha K
    Angiology; 1982 Oct; 33(10):642-51. PubMed ID: 6751163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New aspects of thromboangiitis obliterans (von Winiwarter-Buerger's disease).
    Berlit P; Kessler C; Reuther R; Krause KH
    Eur Neurol; 1984; 23(6):394-9. PubMed ID: 6391927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of HLA-A9 and HLA-B5 with Buerger's disease.
    McLoughlin GA; Helsby CR; Evans CC; Chapman DM
    Br Med J; 1976 Nov; 2(6045):1165-6. PubMed ID: 990826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological studies in thromboangitis obliterans (Buerger's disease).
    Gulati SM; Singh KS; Thusoo TK; Saha K
    J Surg Res; 1979 Nov; 27(5):287-93. PubMed ID: 390247
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunohistochemical analysis of arterial wall cellular infiltration in Buerger's disease (endarteritis obliterans).
    Kobayashi M; Ito M; Nakagawa A; Nishikimi N; Nimura Y
    J Vasc Surg; 1999 Mar; 29(3):451-8. PubMed ID: 10069909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are anticardiolipin antibodies really important in thromboangiitis obliterans (Buerger's disease)?
    Olin JW
    Vasc Med; 2002; 7(4):257-8. PubMed ID: 12710839
    [No Abstract]   [Full Text] [Related]  

  • 14. Study of anti-neutrophil cytoplasmic antibodies in patients with thromboangiitis obliterans (Buerger's disease).
    Halacheva KS; Manolova IM; Petkov DP; Andreev AP
    Scand J Immunol; 1998 Nov; 48(5):544-50. PubMed ID: 9822265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmunological aspects of thromboangiitis obliterans (Buerger's disease).
    Smolen JS; Youngchaiyud U; Weidinger P; Kojer M; Endler AT; Mayr WR; Menzel EJ
    Clin Immunol Immunopathol; 1978 Oct; 11(2):168-77. PubMed ID: 367656
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of autoimmunity in thromboangiitis obliterans (Buerger's disease).
    Ketha SS; Cooper LT
    Ann N Y Acad Sci; 2013 May; 1285():15-25. PubMed ID: 23510296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Buerger's disease or thromboangiitis obliterans revealed by an enteric ischemia. Case report and literature review].
    Adem C; Benamouzig R; Royer I; Chapel N; Martin A
    Gastroenterol Clin Biol; 2002 Apr; 26(4):409-11. PubMed ID: 12070415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombangitis obliterans: leucocyte subpopulations and circulating immune complexes.
    Kröger K; Kreuzfelder E; Moser C; Santosa F; Buss C; Grosse-Wilde H
    Vasa; 2001 Jul; 30(3):189-94. PubMed ID: 11582949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical properties in the patients with Buerger's disease--possible role of plasminogen activator inhibitor-1 for preservation of vessel wall architecture.
    Sato T; Tamai H; Kobayashi M; Yamamoto K; Komori K
    Cardiovasc Pathol; 2011; 20(5):266-71. PubMed ID: 20708412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G-protein coupled receptor auto-antibodies in thromboangiitis obliterans (Buerger's disease) and their removal by immunoadsorption.
    Klein-Weigel PF; Bimmler M; Hempel P; Schöpp S; Dreusicke S; Valerius J; Bohlen A; Boehnlein JM; Bestler D; Funk S; Elitok S
    Vasa; 2014 Sep; 43(5):347-52. PubMed ID: 25147011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.